Pilot studies are a critical phase in clinical research, aimed at assessing the feasibility of a study design before a larger-scale trial. They help evaluate recruitment, randomization, retention, assessment procedures, and implementation of interventions. However, pilot studies are not hypothesis-testing studies and do not provide reliable effect size estimates or safety data due to small sample sizes. Their primary purpose is to inform feasibility, not efficacy or safety. Pilot results can guide the design of larger studies but should not be used for sample size determination or to infer clinical significance. Pilot studies may include control groups to better assess feasibility, but they are not designed to test hypotheses. Safety data from pilot studies are imprecise, and adverse event reporting should be based on specific criteria. Pilot data should not be combined with data from larger trials unless an adaptive design is used. Pilot studies are essential for exploring novel interventions but have limitations in generalizing results beyond their inclusion/exclusion criteria. They help reduce the risk of failed trials by identifying feasibility issues early. Sample size determination for larger studies should be based on clinically meaningful effects rather than pilot data. Pilot studies are not suitable for evaluating population effect sizes due to their small scale. Overall, pilot studies are a necessary first step in clinical research but must be interpreted with caution to avoid misinterpretation of their limitations.Pilot studies are a critical phase in clinical research, aimed at assessing the feasibility of a study design before a larger-scale trial. They help evaluate recruitment, randomization, retention, assessment procedures, and implementation of interventions. However, pilot studies are not hypothesis-testing studies and do not provide reliable effect size estimates or safety data due to small sample sizes. Their primary purpose is to inform feasibility, not efficacy or safety. Pilot results can guide the design of larger studies but should not be used for sample size determination or to infer clinical significance. Pilot studies may include control groups to better assess feasibility, but they are not designed to test hypotheses. Safety data from pilot studies are imprecise, and adverse event reporting should be based on specific criteria. Pilot data should not be combined with data from larger trials unless an adaptive design is used. Pilot studies are essential for exploring novel interventions but have limitations in generalizing results beyond their inclusion/exclusion criteria. They help reduce the risk of failed trials by identifying feasibility issues early. Sample size determination for larger studies should be based on clinically meaningful effects rather than pilot data. Pilot studies are not suitable for evaluating population effect sizes due to their small scale. Overall, pilot studies are a necessary first step in clinical research but must be interpreted with caution to avoid misinterpretation of their limitations.